Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paul Daniel Donohoue is active.

Publication


Featured researches published by Paul Daniel Donohoue.


Molecular Cell | 2014

Guide RNA Functional Modules Direct Cas9 Activity and Orthogonality

Alexandra E. Briner; Paul Daniel Donohoue; Ahmed A. Gomaa; Kurt Selle; Euan Slorach; Christopher Nye; Rachel E. Haurwitz; Chase L. Beisel; Andrew Paul May; Rodolphe Barrangou

The RNA-guided Cas9 endonuclease specifically targets and cleaves DNA in a sequence-dependent manner and has been widely used for programmable genome editing. Cas9 activity is dependent on interactions with guide RNAs, and evolutionarily divergent Cas9 nucleases have been shown to work orthogonally. However, the molecular basis of selective Cas9:guide-RNA interactions is poorly understood. Here, we identify and characterize six conserved modules within native crRNA:tracrRNA duplexes and single guide RNAs (sgRNAs) that direct Cas9 endonuclease activity. We show the bulge and nexus are necessary for DNA cleavage and demonstrate that the nexus and hairpins are instrumental in defining orthogonality between systems. In contrast, the crRNA:tracrRNA complementary region can be modified or partially removed. Collectively, our results establish guide RNA features that drive DNA targeting by Cas9 and open new design and engineering avenues for CRISPR technologies.


Nature Methods | 2017

Mapping the genomic landscape of CRISPR-Cas9 cleavage

Peter Cameron; Christopher K. Fuller; Paul Daniel Donohoue; Brittnee N. Jones; Matthew S. Thompson; Matthew Merrill Carter; Scott Gradia; Bastien Vidal; Elizabeth Garner; Euan Slorach; Elaine Lau; Lynda M Banh; Alexandra M Lied; Leslie S Edwards; Alexander H. Settle; Daniel Capurso; Victor Llaca; Stéphane Deschamps; Mark Cigan; Joshua K. Young; Andrew May

RNA-guided CRISPR–Cas9 endonucleases are widely used for genome engineering, but our understanding of Cas9 specificity remains incomplete. Here, we developed a biochemical method (SITE-Seq), using Cas9 programmed with single-guide RNAs (sgRNAs), to identify the sequence of cut sites within genomic DNA. Cells edited with the same Cas9–sgRNA complexes are then assayed for mutations at each cut site using amplicon sequencing. We used SITE-Seq to examine Cas9 specificity with sgRNAs targeting the human genome. The number of sites identified depended on sgRNA sequence and nuclease concentration. Sites identified at lower concentrations showed a higher propensity for off-target mutations in cells. The list of off-target sites showing activity in cells was influenced by sgRNP delivery, cell type and duration of exposure to the nuclease. Collectively, our results underscore the utility of combining comprehensive biochemical identification of off-target sites with independent cell-based measurements of activity at those sites when assessing nuclease activity and specificity.


Archive | 2014

Compositions and methods of nucleic acid-targeting nucleic acids

Andrew Paul May; Rachel E. Haurwitz; Jennifer A. Doudna; James M. Berger; Matthew Merrill Carter; Paul Daniel Donohoue


Trends in Biotechnology | 2017

Advances in Industrial Biotechnology Using CRISPR-Cas Systems

Paul Daniel Donohoue; Rodolphe Barrangou; Andrew Paul May


Archive | 2015

RNA Modification to Engineer Cas9 Activity

Andrew May; Paul Daniel Donohoue; Christopher Nye; Euan Slorach; Rachel E. Haurwitz


Archive | 2017

COMPOSITIONS AND METHODS OF ENGINEERED CRISPR-CAS9 SYSTEMS USING SPLIT-NEXUS CAS9-ASSOCIATED POLYNUCLEOTIDES

Paul Daniel Donohoue; Andrew Paul May


Archive | 2016

CRISPR-Cas Compositions and Methods

Paul Daniel Donohoue; Andrew Paul May; Katharina Friederike Sonja Stengel


Archive | 2017

Engineered Nucleic-Acid Targeting Nucleic Acids

Paul Daniel Donohoue; Andrew Paul May


Archive | 2017

Methods of using engineered nucleic-acid targeting nucleic acids

Paul Daniel Donohoue; Andrew Paul May


Archive | 2017

Cells comprising engineered nucleic-acid targeting nucleic acids

Paul Daniel Donohoue; Andrew Paul May

Collaboration


Dive into the Paul Daniel Donohoue's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Euan Slorach

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

James M. Berger

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rodolphe Barrangou

North Carolina State University

View shared research outputs
Top Co-Authors

Avatar

Ahmed A. Gomaa

North Carolina State University

View shared research outputs
Top Co-Authors

Avatar

Alexandra E. Briner

North Carolina State University

View shared research outputs
Researchain Logo
Decentralizing Knowledge